Genovyn Appoints Industry Veterans Sammy Bell as Chief Scientific Officer and Jim Edinger as Chief Development Officer to Accelerate AI-Enabled Therapeutic Discovery and Development
GlobeNewswire·June 4, 2026
Genovyn appoints biotech leaders Sammy Bell, Ph.D., as CSO and Jim Edinger, Ph.D., as CDO to advance AI-enabled discovery....
This article was sourced from GlobeNewswire. Read the full article at the original publisher.
Read full article at GlobeNewswire →